Found: 231
Select item for more details and to access through your institution.
Price variability of TNF‐α inhibitor biosimilars among European countries.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 8, p. e663, doi. 10.1111/jdv.19756
- By:
- Publication type:
- Article
Managing the Patient with Psoriasis and Metabolic Comorbidities.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 4, p. 527, doi. 10.1007/s40257-024-00857-0
- By:
- Publication type:
- Article
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis).
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 6, p. 1649, doi. 10.1007/s13555-024-01182-4
- By:
- Publication type:
- Article
Awareness of obesity among patients with psoriasis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 5, p. e391, doi. 10.1111/jdv.19617
- By:
- Publication type:
- Article
Head-neck melanoma: Clinical, histopathological and prognostic features of an Italian multicentric study.
- Published in:
- JEADV Clinical Practice, 2024, v. 3, n. 1, p. 76, doi. 10.1002/jvc2.250
- By:
- Publication type:
- Article
Generalized pustular psoriasis successfully treated with spesolimab: A case report.
- Published in:
- SAGE Open Medical Case Reports, 2024, p. 1, doi. 10.1177/2050313X241235451
- By:
- Publication type:
- Article
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis).
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1341708
- By:
- Publication type:
- Article
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS).
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 495, doi. 10.3390/jcm13020495
- By:
- Publication type:
- Article
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 1, p. 127, doi. 10.1007/s40257-023-00810-7
- By:
- Publication type:
- Article
AtopyReg<sup>®</sup>, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History.
- Published in:
- American Journal of Clinical Dermatology, 2024, v. 25, n. 1, p. 149, doi. 10.1007/s40257-023-00819-y
- By:
- Publication type:
- Article
Correction to: AtopyReg<sup>®</sup>, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Long-term follow-up of Zoon balanitis: a retrospective cohort study.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 1, p. 1, doi. 10.1007/s00403-023-02769-1
- By:
- Publication type:
- Article
Fast and safe clinical response to sonidegib in a 98-year-old woman affected by locally advanced basal cell carcinoma.
- Published in:
- Dermatology Online Journal, 2024, v. 30, n. 1, p. 1, doi. 10.5070/D330163292
- By:
- Publication type:
- Article
Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate‐to‐severe atopic dermatitis in adults: A multicentre real‐world study.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 1, p. e11, doi. 10.1111/jdv.19382
- By:
- Publication type:
- Article
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study.
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2023, v. 16, p. 3561, doi. 10.2147/CCID.S416149
- By:
- Publication type:
- Article
Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 10, p. 2171, doi. 10.1007/s13555-023-01014-x
- By:
- Publication type:
- Article
The transition from mild to moderate‐to‐severe chronic plaque psoriasis.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 10, p. e1215, doi. 10.1111/jdv.19208
- By:
- Publication type:
- Article
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 18, p. 6057, doi. 10.3390/jcm12186057
- By:
- Publication type:
- Article
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 5, p. 1149, doi. 10.1007/s13555-023-00917-z
- By:
- Publication type:
- Article
Overview of Atopic Dermatitis in Different Ethnic Groups.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 7, p. 2701, doi. 10.3390/jcm12072701
- By:
- Publication type:
- Article
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 740, doi. 10.3390/vaccines11040740
- By:
- Publication type:
- Article
Shedding Light on Novel Pathogenic and Therapeutic Aspects Related to Immune-Mediated Skin Diseases.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 761, doi. 10.3390/vaccines11040761
- By:
- Publication type:
- Article
Recurrent cutaneous eosinophilic vasculitis characterized by annular purpuric lesions: A case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Cantú syndrome: A new case and evolution of clinical conditions during first 2‐year follow‐up.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Advanced Glycation End Products and Psoriasis.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 617, doi. 10.3390/vaccines11030617
- By:
- Publication type:
- Article
The Treat-to-Target Project in Atopic Dermatitis: One Year On.
- Published in:
- Acta Dermato-Venereologica, 2023, v. 103, p. 1, doi. 10.2340/actadv.v103.5382
- By:
- Publication type:
- Article
Atopic Dermatitis in the Elderly Population.
- Published in:
- Acta Dermato-Venereologica, 2023, v. 103, p. 1, doi. 10.2340/actadv.v103.13363
- By:
- Publication type:
- Article
Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis).
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 1, p. 93, doi. 10.1111/jdv.18594
- By:
- Publication type:
- Article
Safety of tralokinumab in adult patients with moderate‐to‐severe atopic dermatitis: pooled analysis of five randomized, double‐blind, placebo‐controlled phase II and phase III trials*.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 6, p. 888, doi. 10.1111/bjd.21867
- By:
- Publication type:
- Article
Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1049079
- By:
- Publication type:
- Article
Predictors of subsequent primary melanoma: a case–control study.
- Published in:
- Archives of Dermatological Research, 2022, v. 314, n. 9, p. 881, doi. 10.1007/s00403-021-02309-9
- By:
- Publication type:
- Article
Pyoderma gangrenosum associated with pseudo-Pelger-Huët anomaly in a patient with idiopathic myelofibrosis.
- Published in:
- Dermatology Online Journal, 2022, v. 28, n. 6, p. 1, doi. 10.5070/D328659742
- By:
- Publication type:
- Article
Multidisciplinary management of type 2 inflammatory diseases.
- Published in:
- Multidisciplinary Respiratory Medicine, 2022, v. 17, p. 10, doi. 10.4081/mrm.2022.813
- By:
- Publication type:
- Article
Contact allergy in children with and without atopic dermatitis: An Italian multicentre study.
- Published in:
- Contact Dermatitis (01051873), 2022, v. 87, n. 3, p. 265, doi. 10.1111/cod.14130
- By:
- Publication type:
- Article
Dupilumab for recalcitrant Kimura disease.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 9, p. 1, doi. 10.1111/dth.15674
- By:
- Publication type:
- Article
Durability of Response to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis After Treatment Discontinuation in a Phase 2b Trial.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 9, p. 2077, doi. 10.1007/s13555-022-00764-4
- By:
- Publication type:
- Article
Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort Study.
- Published in:
- Drugs in R&D, 2022, v. 22, n. 3, p. 245, doi. 10.1007/s40268-022-00396-1
- By:
- Publication type:
- Article
National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 17, p. 5204, doi. 10.3390/jcm11175204
- By:
- Publication type:
- Article
Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1475, doi. 10.3390/vaccines10091475
- By:
- Publication type:
- Article
Real life long‐term efficacy and safety of ixekizumab in moderate‐to‐severe psoriasis: A 192 weeks multicentric retrospective study—IL PSO (Italian landscape psoriasis).
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 8, p. 1, doi. 10.1111/dth.15608
- By:
- Publication type:
- Article
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis.
- Published in:
- Psoriasis: Targets & Therapy, 2022, v. 12, p. 213, doi. 10.2147/PTT.S323300
- By:
- Publication type:
- Article
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study.
- Published in:
- Vaccines, 2022, v. 10, n. 8, p. 1171, doi. 10.3390/vaccines10081171
- By:
- Publication type:
- Article
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 6, p. 1303, doi. 10.1007/s13555-022-00732-y
- By:
- Publication type:
- Article
Uncommon non-infectious annular dermatoses.
- Published in:
- Indian Journal of Dermatology, 2022, v. 67, n. 3, p. 313, doi. 10.4103/ijd.ijd_743_21
- By:
- Publication type:
- Article
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 646, doi. 10.3390/vaccines10050646
- By:
- Publication type:
- Article
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Primary nodular localized cutaneous amyloidosis of the scalp associated with systemic lupus erythematosus.
- Published in:
- Archives of Rheumatology, 2022, v. 37, n. 1, p. 145, doi. 10.46497/ArchRheumatol.2022.8817
- By:
- Publication type:
- Article
Hypochondriasis and Personality Traits of Patients with Chronic Plaque Psoriasis.
- Published in:
- Dermatology (10188665), 2022, v. 238, n. 2, p. 276, doi. 10.1159/000517018
- By:
- Publication type:
- Article
A case of nivolumab-induced bullous pemphigoid successfully treated with dupilumab.
- Published in:
- Dermatology Online Journal, 2022, v. 28, n. 2, p. 1, doi. 10.5070/D328257396
- By:
- Publication type:
- Article
Flare management in atopic dermatitis: from definition to treatment.
- Published in:
- Therapeutic Advances in Chronic Disease, 2022, p. 1, doi. 10.1177/20406223211066728
- By:
- Publication type:
- Article